ArbitrationIntel — For People Harmed By GLP-1 Drugs
Ozempic, Wegovy, and Mounjaro are under a nationwide lawsuit over gastroparesis, stomach paralysis, and severe intestinal injuries the makers may not have adequately warned patients about. If you were diagnosed after taking a GLP-1 drug, ArbitrationIntel can match you with a vetted law firm handling these claims — free to check, and in most cases free to start.
I. What The Ozempic Lawsuit Is About
Ozempic, Wegovy, Mounjaro, Trulicity, Saxenda, and Rybelsus belong to a class of drugs called GLP-1 receptor agonists, approved to treat type 2 diabetes and, increasingly, prescribed off-label or on-label for weight loss. Lawsuits against the manufacturers allege they knew — or should have known — about a heightened risk of severe gastrointestinal injury, including gastroparesis (stomach paralysis), intestinal obstruction, ileus, and gallbladder disease, and failed to warn patients and doctors clearly enough. If you took one of these drugs and ended up with a diagnosis like that, that gap between what the label said and what happened to your body may be the basis of a claim.
II. The Consolidated Litigation
MDL 3094
Claims from people injured by Ozempic, Wegovy, and related GLP-1 drugs have been consolidated into a multidistrict litigation — MDL No. 3094 — in the U.S. District Court for the Eastern District of Pennsylvania. Consolidation doesn't combine everyone into one lawsuit; it lets thousands of individual claims share the same evidence about what the manufacturers knew about the injury risk and when, so no one has to start from zero. Your case is still your own, evaluated on your own diagnosis, timeline, and medical records.
III. How It Works
Which drug, roughly when you started it, and what you were diagnosed with — a few plain-language questions, no medical forms to file.
If your timeline and diagnosis fit the litigation, we match you with a law firm already handling GLP-1 injury cases.
The firm requests your records and takes it from there. In most cases, you pay nothing unless the case succeeds.
IV. Symptoms & Diagnoses That May Qualify
Gastroparesis (stomach paralysis)
Diagnosed after starting Ozempic, Wegovy, Mounjaro, or a similar drug — food sits in the stomach far longer than it should.
Severe, repeated vomiting
Nausea or vomiting bad enough to require an ER visit or hospital stay.
Bowel obstruction or ileus
The intestines slow or stop moving, sometimes requiring surgery.
Gallbladder disease
Gallstones or gallbladder removal after starting a GLP-1 drug.
Symptoms that didn't resolve after stopping
Digestive injury that continued even after you stopped taking the medication.
V. Questions People Ask First
No. Checking your claim is free. In most cases, you don't pay anything unless your case succeeds — the firm's fee comes out of any recovery, not your pocket. Fee terms are set by the participating firm and can vary by state.
Ozempic, Wegovy, and Mounjaro are the most commonly named, alongside other GLP-1 drugs like Trulicity, Saxenda, and Rybelsus. Whether your specific drug and diagnosis fit is something the reviewing firm will confirm.
No. ArbitrationIntel is a marketplace that connects you with independent, licensed law firms handling GLP-1 injury claims. We're not a law firm, and nothing on this page is legal or medical advice.
Deadlines vary by state and by the date of your diagnosis, and they don't wait. The sooner a firm can review your records, the more options you're likely to have — that's the main reason to check now rather than later.
Whether to keep taking any medication is a decision for you and your doctor, not this page. A reviewing firm can still evaluate a claim based on your diagnosis and history regardless of whether you've stopped.
Yes. What you share is used only to check your claim and, if it qualifies, match you with a firm. It isn't sold to advertisers.
VI. Check Your Claim
Tell us which drug you took and what you were diagnosed with. If it looks like a fit, we'll match you with a law firm already handling GLP-1 injury claims — no cost to check, and in most cases no cost to start.